← FDA DRUG APPROVALS

FDA ANDA · ANDA078808

GRANISETRON HYDROCHLORIDE

Sponsor: SANDOZ

APPLICATION
ANDA078808
TYPE
ANDA
ORIGINAL APPROVAL
2008-04-29
LATEST ACTION
2015-06-13
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

GRANISETRON HYDROCHLORIDEDiscontinued
GRANISETRON HYDROCHLORIDE EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) · INJECTABLE · INJECTION

Approval history

2015-06-13Labeling · Supplement 12 · standardAP
2014-09-18Labeling · Supplement 11 · standardAP
2014-09-03Labeling · Supplement 7 · standardAP
2012-04-17Labeling · Supplement 6AP
2008-04-29OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →